BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 19033198)

  • 1. Nucleophosmin interacts directly with c-Myc and controls c-Myc-induced hyperproliferation and transformation.
    Li Z; Boone D; Hann SR
    Proc Natl Acad Sci U S A; 2008 Dec; 105(48):18794-9. PubMed ID: 19033198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Myc-nucleophosmin-ARF network: a complex web unveiled.
    Li Z; Hann SR
    Cell Cycle; 2009 Sep; 8(17):2703-7. PubMed ID: 19652540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleophosmin is essential for c-Myc nucleolar localization and c-Myc-mediated rDNA transcription.
    Li Z; Hann SR
    Oncogene; 2013 Apr; 32(15):1988-94. PubMed ID: 22665062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Nucleolar Protein GLTSCR2 Is an Upstream Negative Regulator of the Oncogenic Nucleophosmin-MYC Axis.
    Kim JY; Cho YE; Park JH
    Am J Pathol; 2015 Jul; 185(7):2061-8. PubMed ID: 25956029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic c-Myc-induced lymphomagenesis is inhibited non-redundantly by the p19Arf-Mdm2-p53 and RP-Mdm2-p53 pathways.
    Meng X; Carlson NR; Dong J; Zhang Y
    Oncogene; 2015 Nov; 34(46):5709-17. PubMed ID: 25823025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Egr1 mediates p53-independent c-Myc-induced apoptosis via a noncanonical ARF-dependent transcriptional mechanism.
    Boone DN; Qi Y; Li Z; Hann SR
    Proc Natl Acad Sci U S A; 2011 Jan; 108(2):632-7. PubMed ID: 21187408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleophosmin protein expression level, but not threonine 198 phosphorylation, is essential in growth and proliferation.
    Brady SN; Maggi LB; Winkeler CL; Toso EA; Gwinn AS; Pelletier CL; Weber JD
    Oncogene; 2009 Sep; 28(36):3209-20. PubMed ID: 19561638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleophosmin suppresses oncogene-induced apoptosis and senescence and enhances oncogenic cooperation in cells with genomic instability.
    Li J; Sejas DP; Burma S; Chen DJ; Pang Q
    Carcinogenesis; 2007 Jun; 28(6):1163-70. PubMed ID: 17277230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism.
    Kinney EL; Tanida S; Rodrigue AA; Johnson JK; Tompkins VS; Sakamuro D
    J Cell Physiol; 2008 Sep; 216(3):621-31. PubMed ID: 18348166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of Myc oncogenic activity by nucleostemin haploinsufficiency.
    Zwolinska AK; Heagle Whiting A; Beekman C; Sedivy JM; Marine JC
    Oncogene; 2012 Jul; 31(28):3311-21. PubMed ID: 22081066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Playing both sides: nucleophosmin between tumor suppression and oncogenesis.
    Di Fiore PP
    J Cell Biol; 2008 Jul; 182(1):7-9. PubMed ID: 18625839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleophosmin is required for DNA integrity and p19Arf protein stability.
    Colombo E; Bonetti P; Lazzerini Denchi E; Martinelli P; Zamponi R; Marine JC; Helin K; Falini B; Pelicci PG
    Mol Cell Biol; 2005 Oct; 25(20):8874-86. PubMed ID: 16199867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical and functional interaction of the TPL2 kinase with nucleophosmin.
    Kanellis DC; Bursac S; Tsichlis PN; Volarevic S; Eliopoulos AG
    Oncogene; 2015 May; 34(19):2516-26. PubMed ID: 24998852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p19ARF directly and differentially controls the functions of c-Myc independently of p53.
    Qi Y; Gregory MA; Li Z; Brousal JP; West K; Hann SR
    Nature; 2004 Oct; 431(7009):712-7. PubMed ID: 15361884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoplasmic localization of Mdm2 in cells expressing mutated NPM is mediated by p53.
    Strachotová D; Holoubek A; Wolfová K; Brodská B; Heřman P
    FEBS J; 2023 Sep; 290(17):4281-4299. PubMed ID: 37119456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis.
    Eischen CM; Roussel MF; Korsmeyer SJ; Cleveland JL
    Mol Cell Biol; 2001 Nov; 21(22):7653-62. PubMed ID: 11604501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ARF impedes NPM/B23 shuttling in an Mdm2-sensitive tumor suppressor pathway.
    Brady SN; Yu Y; Maggi LB; Weber JD
    Mol Cell Biol; 2004 Nov; 24(21):9327-38. PubMed ID: 15485902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of the RP-MDM2-p53 pathway accelerates APC loss-induced colorectal tumorigenesis.
    Liu S; Tackmann NR; Yang J; Zhang Y
    Oncogene; 2017 Mar; 36(10):1374-1383. PubMed ID: 27617574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcription-independent ARF regulation in oncogenic stress-mediated p53 responses.
    Chen D; Shan J; Zhu WG; Qin J; Gu W
    Nature; 2010 Mar; 464(7288):624-7. PubMed ID: 20208519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation.
    Chen H; Liu J; Zhao CQ; Diwan BA; Merrick BA; Waalkes MP
    Toxicol Appl Pharmacol; 2001 Sep; 175(3):260-8. PubMed ID: 11559025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.